Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Sie sind im Begriff, von der lokalen Website für Deutschland auf die globale Website in englischer Sprache zu wechseln. Möchten Sie fortfahren?
Diesen Hinweis nicht wieder anzeigen.
Ja
Nein

Website durchstöbert nach

You Searched For:

Verfeinern nach:

Zugehörige Informationen

Kommende Veranstaltungen

Zugehörige Produkte

Hauptansprechpartner

Naher/Mittlerer Osten - Pennsylvania

Aktuelles

Research
Organisationen
Bitte verfeinern Sie Ihre Suche nach Marktsegment um entsprechende Ratingaktivitäten und Watchlist-Einträge anzeigen zu lassen
  DatumDokument-Art Titel Emittent/Unternehmen
17 Dec 2023 Rating Action Moody's affirms Teva's Ba2 ratings; outlook stable Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
27 Jul 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers AbbVie Inc.
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
Bausch Health C...
...
14 Jun 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Chemical issuers Akzo Nobel N.V.
Arkema S.A.
BASF (SE)
BASF Finance Eu...
Bayer AG
Bayer Capital C...
Bayer Corporati...
Bayer Holding L...
Bayer Nordic SE
Bayer US Financ...
...
25 Apr 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Asset Managers issuers 3i Group plc
abrdn plc
Affiliated Mana...
AllianceBernste...
AllSpring Buyer...
AllSpring Inter...
AMP Group Finan...
AMP Group Holdi...
Apollo Asset Ma...
BlackRock, Inc.
...
04 Oct 2022 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers AbbVie Inc.
Akorn Operating...
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
...
20 May 2022 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Asset Managers issuers 3i Group plc
abrdn plc
Affiliated Mana...
AllianceBernste...
AllSpring Buyer...
AllSpring Inter...
AMP Group Finan...
AMP Group Holdi...
BlackRock, Inc.
BrightSphere In...
...
15 Dec 2021 Rating Action Moody's affirms Teva's Ba2 ratings; outlook revised to stable Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
08 Nov 2021 Announcement of Periodic Review Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
15 Dec 2020 Announcement of Periodic Review Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd Teva Pharmaceut...
Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
22 Oct 2020 Announcement Moody's withdraws Green Bond Assessments (GBA) American Munici...
American Munici...
Arise AB
Axis Bank Limit...
Banco Nacional ...
Bank of Communi...
Cape Town, City...
Consorcio Trans...
District of Col...
E3 2019-1
...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry